T. MacDonald

First name
T.
Middle name
M.
Last name
MacDonald
Mackenzie, I. S., Morant, S. V., Wei, L., Thompson, A. M., & MacDonald, T. M. (2017). Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13152
Fortuny, J., Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., et al. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Saf. http://doi.org/10.1007/s40264-019-00836-z
Wei, L., Lai, E. C., Kao-Yang, Y. H., Walker, B. R., MacDonald, T. M., & Andrew, R. (2019). Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study. Bmj. http://doi.org/10.1136/bmj.l1204
Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., et al. (2019). Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-019-00835-0
Ruigomez, A., Plana, E., Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Flynn, R. W. V., et al. (2021). Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride. Drug Saf. http://doi.org/10.1007/s40264-021-01044-4